No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / pharmacology
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Benzenesulfonates / pharmacology*
-
Binding, Competitive
-
Clinical Trials, Phase II as Topic
-
Cytarabine / pharmacology*
-
Drug Synergism
-
Eukaryotic Initiation Factor-4E / antagonists & inhibitors*
-
Humans
-
Idarubicin / pharmacology*
-
Leukemia, Myeloid, Acute / drug therapy*
-
Leukemia, Myeloid, Acute / pathology
-
Leukemia, Myelomonocytic, Acute / drug therapy*
-
Leukemia, Myelomonocytic, Acute / pathology
-
Middle Aged
-
Niacinamide / analogs & derivatives
-
Phenylurea Compounds
-
Pyridines / pharmacology*
-
RNA Caps / antagonists & inhibitors
-
RNA Caps / metabolism
-
Ribavirin / metabolism
-
Ribavirin / pharmacology*
-
Ribavirin / therapeutic use
-
Sorafenib
-
Tumor Cells, Cultured / drug effects
-
Tumor Stem Cell Assay
Substances
-
Benzenesulfonates
-
Eukaryotic Initiation Factor-4E
-
Phenylurea Compounds
-
Pyridines
-
RNA Caps
-
Cytarabine
-
Niacinamide
-
Ribavirin
-
Sorafenib
-
Idarubicin